Published in Blood Weekly, December 15th, 2005
According to recent research published in the American Journal of Neuroradiology, "Intravenous methotrexate (IV-MTX), an effective treatment for ALL, has a significant toxic effect on the central nervous system, with LE being the most common form. The purpose of this study was to use objective quantitative MR imaging to prospectively assess the temporal evolution of LE extent and intensity."
"Forty-five children (low-risk, 10 mol/L/12F; mean age, 5.0 years at diagnosis; standard/high-risk, 11...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.